{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:07:42Z","timestamp":1792260462081,"version":"4.4.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1176131"],"award-info":[{"award-number":["1176131"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001027","name":"Australian Government Department of Health and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dried blood spot (DBS) testing for hepatitis C virus (HCV) RNA provides a sampling option that avoids venepuncture and can be carried out in a nonclinical setting. Large-scale evaluations are needed to understand how DBS testing can reduce HCV burden. This study estimated prevalence of, and factors associated with, HCV RNA and treatment initiation among people enrolled in a state-wide pilot of people testing in the NSW DBS Pilot in New South Wales, Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>People at risk of HIV\/HCV could participate via (1) self-registration online with a DBS collection kit delivered and returned by conventional postal service; or (2) assisted DBS sample collection at a community site or prison. Logistic regression was used to identify factors associated with detectable HCV RNA and treatment initiation within 6 months of testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between September 2017 and December 2020, 5960 people were tested for HCV (76% men, 35% Aboriginal and\/or Torres Strait Islander, 55% recently injected drugs): 21% online self-registration, 34% assisted registration in the community, 45% assisted registration in prison. Fifteen percent had detectable HCV RNA (878\/5960). Overall, 44% (n = 386\/878) of people with current HCV initiated treatment within 6 months (13% online self-registration, 27% assisted registration in the community, 61% assisted registration in prison). Testing in prison compared with the community (adjusted odds ratio [aOR], 4.28; 95% CI, 3.04\u20136.03) was associated with increased odds of treatment initiation. Being a woman compared with a man (aOR, 0.68; 95% CI, 0.47\u20130.97) was associated with reduced treatment initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The NSW DBS Pilot demonstrates the feasibility of using DBS to promote HCV testing and treatment in community and prison settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofad517","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T01:08:07Z","timestamp":1697677687000},"source":"Crossref","is-referenced-by-count":15,"title":["Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-9714","authenticated-orcid":false,"given":"Anna","family":"Conway","sequence":"first","affiliation":[{"name":"The Kirby Institute, UNSW , Sydney , Australia"},{"name":"Centre for Social Research in Health, UNSW , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Stevens","sequence":"additional","affiliation":[{"name":"Centre for Population Health, NSW Ministry of Health , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Murray","sequence":"additional","affiliation":[{"name":"Centre for Population Health, NSW Ministry of Health , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Prain","sequence":"additional","affiliation":[{"name":"Centre for Population Health, NSW Ministry of Health , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherie","family":"Power","sequence":"additional","affiliation":[{"name":"Centre for Population Health, NSW Ministry of Health , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"McNulty","sequence":"additional","affiliation":[{"name":"Sydney Sexual Health Centre , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Carrington","sequence":"additional","affiliation":[{"name":"Centre for Population Health, NSW Ministry of Health , Sydney , Australia"},{"name":"Sydney Sexual Health Centre , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Lu","sequence":"additional","affiliation":[{"name":"Sydney Sexual Health Centre , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kingsland","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Newcastle, Newcastle, Australia"},{"name":"Population Health Research Program, Hunter Medical Research Institute, Newcastle, Australia"},{"name":"Hunter New England Population Health, Hunter New England Local Health District, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"McGrath","sequence":"additional","affiliation":[{"name":"NSW Justice Health & Forensic Mental Health Network , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Read","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Starr","sequence":"additional","affiliation":[{"name":"St Vincent's Centre for Applied Medical Research, St Vincent's Hospital , Sydney , Australia"},{"name":"NSW State Reference Laboratory for HIV, St Vincent's Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Catlett","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW , Sydney , Australia"},{"name":"St Vincent's Centre for Applied Medical Research, St Vincent's Hospital , Sydney , Australia"},{"name":"NSW State Reference Laboratory for HIV, St Vincent's Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Cunningham","sequence":"additional","affiliation":[{"name":"St Vincent's Centre for Applied Medical Research, St Vincent's Hospital , Sydney , Australia"},{"name":"NSW State Reference Laboratory for HIV, St Vincent's Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"2023113021491625700_ofad517-B1","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis","author":"World Health Organization","year":"2016"},{"key":"2023113021491625700_ofad517-B2","author":"Australian Government Department of Health"},{"issue":"Suppl 2","key":"2023113021491625700_ofad517-B3","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/cid\/cit263","article-title":"Understanding barriers to hepatitis C virus care and stigmatization from a social perspective","volume":"57","author":"Treloar","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2023113021491625700_ofad517-B4","doi-asserted-by":"crossref","first-page":"103706","DOI":"10.1016\/j.drugpo.2022.103706","article-title":"Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: the ETHOS Engage study","volume":"105","author":"Valerio","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B5","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/cid\/ciaa571","article-title":"Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023113021491625700_ofad517-B6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B7","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment\u202f: a global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023113021491625700_ofad517-B8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","article-title":"Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs","volume":"107","author":"Harris","year":"2012","journal-title":"Addiction"},{"key":"2023113021491625700_ofad517-B9","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.3390\/v14112463","article-title":"Awareness of HCV status and preferences for testing and treatment among people with recent injecting drug use at a peer-led needle and syringe program: the TEMPO pilot study","volume":"14","author":"Conway","year":"2022","journal-title":"Viruses"},{"key":"2023113021491625700_ofad517-B10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","article-title":"Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia","volume":"61","author":"Bajis","year":"2018","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.drugpo.2015.05.001","article-title":"The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: a systematic review of the literature","volume":"26","author":"Coats","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B12","first-page":"533","article-title":"Interventions to enhance testing and linkage to treatment for hepatitis C infection: a systematic review and meta-analysis","volume":"6","author":"Cunningham","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2023113021491625700_ofad517-B13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/jiac049","article-title":"Diagnostic accuracy of assays using point-of-care testing or dried blood spot samples for the determination of hepatitis C virus RNA: a systematic review","volume":"226","author":"Catlett","year":"2022","journal-title":"J Infect Dis"},{"key":"2023113021491625700_ofad517-B14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4269\/ajtmh.17-0889","article-title":"Review article: dried blood spots for global health diagnostics and surveillance: opportunities and challenges","volume":"99","author":"Lim","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2023113021491625700_ofad517-B15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/flgastro-2016-100776","article-title":"A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland","volume":"8","author":"Radley","year":"2017","journal-title":"Frontline Gastroenterol"},{"key":"2023113021491625700_ofad517-B16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jiaa442","article-title":"Evaluation of the Aptima HCV Quant Dx assay for hepatitis C virus RNA detection from fingerstick capillary dried blood spot and venepuncture-collected samples","volume":"223","author":"Catlett","year":"2021","journal-title":"J Infect Dis"},{"key":"2023113021491625700_ofad517-B17","doi-asserted-by":"crossref","first-page":"100093","DOI":"10.1016\/j.jcvp.2022.100093","article-title":"Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection","volume":"2","author":"Catlett","year":"2022","journal-title":"J Clin Virol Plus"},{"key":"2023113021491625700_ofad517-B18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcv.2019.01.010","article-title":"Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots","volume":"112","author":"Catlett","year":"2019","journal-title":"J Clin Virol"},{"key":"2023113021491625700_ofad517-B19","author":"Heard"},{"key":"2023113021491625700_ofad517-B20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S2468-1253(20)30303-4","article-title":"Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis","volume":"6","author":"Jin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2023113021491625700_ofad517-B21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/v14071496","article-title":"Time to hepatitis C RNA testing and treatment in the era of direct-acting antiviral therapy among people with hepatitis C in New South Wales, Australia","volume":"14","author":"Yousafzai","year":"2022","journal-title":"Viruses"},{"key":"2023113021491625700_ofad517-B22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/v14071555","article-title":"A testing campaign intervention consisting of peer-facilitated engagement, point-of-care HCV RNA testing, and linkage to nursing support to enhance hepatitis C treatment uptake among people who inject drugs: the ETHOS Engage study","volume":"14","author":"Conway","year":"2022","journal-title":"Viruses"},{"key":"2023113021491625700_ofad517-B23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jvh.13233","article-title":"Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: the LiveRLife study","volume":"27","author":"Bajis","year":"2020","journal-title":"J Viral Hepat"},{"key":"2023113021491625700_ofad517-B24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/v15020521","article-title":"Evaluation of simplified HCV diagnostics in HIV\/HCV co-infected patients in Myanmar","volume":"15","author":"Nyein","year":"2023","journal-title":"Viruses"},{"key":"2023113021491625700_ofad517-B25","author":"NHS England"},{"key":"2023113021491625700_ofad517-B26","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.drugpo.2019.102608","article-title":"Time matters: point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England","volume":"75","author":"Mohamed","year":"2020","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","article-title":"A \u2018one-stop-shop\u2019 point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: the PIVOT study","volume":"79","author":"Sheehan","year":"2023","journal-title":"J Hepatol"},{"key":"2023113021491625700_ofad517-B28","doi-asserted-by":"crossref","DOI":"10.1111\/dar.13688","article-title":"Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: a population-based study","author":"Valerio","year":"2023","journal-title":"Drug Alcohol Rev."},{"key":"2023113021491625700_ofad517-B29","doi-asserted-by":"crossref","first-page":"103654","DOI":"10.1016\/j.drugpo.2022.103654","article-title":"A gender lens is needed in hepatitis C elimination research","volume":"103","author":"Larney","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","article-title":"Accessible hepatitis C care for people who inject drugs: a randomized clinical trial","volume":"182","author":"Eckhardt","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2023113021491625700_ofad517-B31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jvh.12929","article-title":"Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: a surveillance-based propensity score matching approach","volume":"25","author":"Deming","year":"2018","journal-title":"J Viral Hepat"},{"key":"2023113021491625700_ofad517-B32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S2468-1253(22)00355-7","article-title":"A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia","volume":"8","author":"Grebely","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2023113021491625700_ofad517-B33","doi-asserted-by":"crossref","first-page":"103982","DOI":"10.1016\/j.drugpo.2023.103982","article-title":"Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: the TEMPO pilot study","volume":"114","author":"Grebely","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2023113021491625700_ofad517-B34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2468-1253(22)00346-6","article-title":"Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis","volume":"8","author":"Trickey","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad517\/52975071\/ofad517.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/11\/ofad517\/53899032\/ofad517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/11\/ofad517\/53899032\/ofad517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:49:51Z","timestamp":1701362991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad517\/7324801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad517","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,10,20]]},"article-number":"ofad517"}}